Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels
3.6.2021 15:30:00 EEST | Business Wire | Press release
Crown Bioscience (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI) of the National Institute of Health (NIH). By entering into five-year agreements with these premier biomaterial resource providers, CrownBio clients will directly benefit from a priority status that will make cell lines more readily available with simplified logistics.
Through its XenoSelect™ and OmniScreen™ panels, CrownBio already offers its clients highly customizable, broad in vitro screening panel services, paired with industry-leading bioinformatics capabilities and a breadth of established “matched” downstream in vivo models. CrownBio clients will now have access to an extended and unrivaled portfolio of cell lines, with the knowledge and peace of mind that all necessary licensing is in place.
The license agreement with ATCC grants CrownBio expedited access to more than 140 cell lines and associated datasets, as well as future access to an additional 4000 cell lines through an umbrella licensing structure. Similarly, to meet CrownBio’s ongoing global client needs for supplies of NIH cell lines, a new portfolio license has been signed with the NIH. With this agreement, CrownBio will provide access to 100 cell lines available through the NCI Repository of Tumors and Tumor Cell Lines and other sources, that were developed in NCI labs.
Henry Li, PhD, CSO of CrownBio said, “We greatly value our relationships with both ATCC and NIH, which are two of CrownBio’s largest cell line partners. We are excited that these new agreements will enable us to offer our clients expanded and prioritized cell line availability and supply. Together, these agreements exemplify CrownBio’s dedication to ensuring our clients have easy access to an industry-leading range of in vitro and in vivo models for drug discovery.”
###
About Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, immuno-oncology and immune-mediated inflammatory disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, visit: www.crownbio.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210603005538/en/
Contact information
Media Inquiries
Mike Beyer
Sam Brown Inc.
+1 312-961-2502
mikebeyer@sambrown.com
Company Inquiries
Gavin Cooper
Crown Bioscience Inc.
+1 518-488-9062
gavin.cooper@crownbio.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Optimum Asset Management’s Investor Summit in Portofino brings together Mike Pompeo, Matteo Renzi and leaders across government, finance and industry to discuss the future of the global economy and geopolitics16.6.2026 10:30:00 EEST | Press release
The first edition of the Optimum Investors Summit – The Portofino Conversation, hosted by European real estate private equity investment firm Optimum Asset Management and its Italian partners Alberto Matta, Rodolfo Misitano, Enrico Imbraguglio and Andrea Suriano, concluded with strong participation from institutional investors (including pension funds), entrepreneurs, government representatives and financial market professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615915564/en/ Alberto Matta, Managing Partner at Optimum Asset Management, in discussion with Mike Pompeo, former United States Secretary of State and Director of the CIA. Credit: Optimum Asset Management For three days, the Italian Riviera became a hub for discussion on the key economic, geopolitical and financial issues reshaping the global landscape. Discussions were moderated by Andrea Ruggeri, former spokesman for Prime Minister Silvio Berluscon
Elite Tech, Accessible Price - Introducing the Logitech G3 Series Mouse and Keyboard for PC Gaming16.6.2026 10:05:00 EEST | Press release
Logitech G today announced the expansion of the G3 Series suite of PC Gaming products. Designed to bring pro-inspired performance to more gamers, the extended lineup features the G305 X SUPERLIGHT wireless gaming mouse and the G316 X 98 wired mechanical gaming keyboard. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616324864/en/ Logitech G today announced the expansion of the G3 Series suite of PC Gaming products. Designed to bring pro-inspired performance to more gamers, the extended lineup features the G305 X SUPERLIGHT wireless gaming mouse and the G316 X 98 wired mechanical gaming keyboard. These new products join the recently launched Logitech G325 gaming headset, completing the G3 series, a comprehensive high-performance desktop ecosystem that delivers excellent performance, world-class features, and unique customization at an affordable price point. “By fusing elite precision, like our sub-micron HERO 44K sensor a
Eurooppalaisia yrityksiä uhkaa "näkyvyyskuilu", kun tekoäly määrittelee hakua ja asiakashankintaa uudelleen16.6.2026 10:00:00 EEST | Tiedote
Eurooppalaisilla yrityksillä on aiempaa vaikeampaa tavoittaa asiakkaita verkossa, ja ne kamppailevat epäselvyyden kanssa siitä, mikä ajaa kasvua. Näin kertoo digitaalinen ekosysteemipalveluntarjoaja team.bluen ensimmäinen vuotuinen Euroopan liiketoiminnan tila -raportti. Yli 10 000 yritykseltä 32 maassa tehty tutkimus varoittaa kasvavasta "näkyvyyskuilusta" eurooppalaisille yrityksille – syvenevästi katkoksesta heidän verkkonäkyvyytensä ja kyvykkyytensä välillä ymmärtää, vaikuttaa ja mitata sitä, miten asiakkaat löytävät heidät. Asiakashankintamaailma muuttuu nopeammin kuin useimmat yritykset ehtivät sopeutua: lähes joka kolmas yritys (30,6 %) raportoi, että asiakkaiden tavoittaminen verkossa on vaikeutunut viimeisen kahden vuoden aikana. Löytämisen kenttä on samanaikaisesti rikkaampi ja pirstaloituneempi kuin koskaan ennen – dynamiikka, jonka team.blue on nimennyt "Näkyvyystaloudeksi" (Visibility Economy). Yritysten luottamus siihen, miten asiakkaat löytävät heidät, on heikentynyt Kun
Tampere Philharmonic Orchestra Appoints Kristian Sallinen as the Next Chief Conductor16.6.2026 10:00:00 EEST | Press release
Kristian Sallinen has been appointed Chief Conductor and Artistic Director of the Tampere Philharmonic Orchestra. He will begin his three-year term in August 2027, following the tenure of British conductor Matthew Halls. Sallinen will conduct a minimum of 7–8 programmes each season alongside other projects and will become the thirteenth Chief Conductor in the Finnish orchestra’s 96-year history. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615800659/en/ Conductor Kristian Sallinen will begin his tenure as the new Chief Conductor of the Tampere Philharmonic Orchestra in August 2027. Photo: Antti Rintala. Sallinen last appeared in Tampere in September 2025, conducting Richard Strauss’s Der Rosenkavalier Suite and Magnus Lindberg’s Concerto for Orchestra. He will return this September to lead a programme of Finnish music by Jean Sibelius, Kaija Saariaho and Väinö Raitio. – I am deeply honoured and grateful for the trust th
ABB Robotics and PSYONIC Use Human-Generated Data to Advance Robotic Dexterity16.6.2026 07:01:00 EEST | Press release
ABB Robotics is collaborating with California bionics company, PSYONIC, to advance robotic gripping and dexterity using a new approach that utilizes real-world manipulation data from human prosthetic use. By combining the PSYONIC Ability Hand with an ABB GoFa™ cobot, the collaboration will explore how touch and motion data generated by human prosthetic use can be used to train robots to perform delicate, variable tasks that have traditionally been difficult to automate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612749544/en/ “Human dexterity and the instinctive understanding of how to handle different objects is one of the most difficult things to replicate in industrial-grade robotics, but it’s a fundamental need for truly autonomous and versatile robots,” said Marc Segura, President, ABB Robotics. “As we develop the next generation physical AI, robots will learn and understand the world as we do. This collaboration
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom